Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2015 | 13 | 0.500 |
Why?
|
| Molecular Motor Proteins | 1 | 2015 | 31 | 0.490 |
Why?
|
| Myosin Heavy Chains | 1 | 2015 | 92 | 0.480 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2015 | 50 | 0.480 |
Why?
|
| Anemia, Sideroblastic | 1 | 2014 | 7 | 0.460 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 160 | 0.450 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 187 | 0.450 |
Why?
|
| Copper | 1 | 2014 | 78 | 0.440 |
Why?
|
| Zinc | 1 | 2014 | 95 | 0.440 |
Why?
|
| Neutropenia | 1 | 2014 | 214 | 0.430 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 360 | 0.360 |
Why?
|
| Hyperhomocysteinemia | 1 | 2007 | 11 | 0.290 |
Why?
|
| Homocysteine | 1 | 2007 | 30 | 0.280 |
Why?
|
| Bone Marrow | 2 | 2014 | 443 | 0.270 |
Why?
|
| Thromboembolism | 1 | 2007 | 122 | 0.270 |
Why?
|
| Anemia | 1 | 2001 | 132 | 0.170 |
Why?
|
| Erythrocyte Indices | 1 | 1999 | 9 | 0.160 |
Why?
|
| Thalassemia | 1 | 1999 | 16 | 0.160 |
Why?
|
| Cell Nucleus | 1 | 2001 | 602 | 0.160 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 1999 | 20 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 1606 | 0.150 |
Why?
|
| Biopsy | 3 | 2014 | 1185 | 0.140 |
Why?
|
| Multiple Myeloma | 1 | 2001 | 334 | 0.140 |
Why?
|
| Splenectomy | 1 | 2015 | 82 | 0.120 |
Why?
|
| Bone Marrow Examination | 1 | 2014 | 47 | 0.110 |
Why?
|
| Castleman Disease | 1 | 2014 | 14 | 0.110 |
Why?
|
| Hyperplasia | 1 | 2014 | 152 | 0.110 |
Why?
|
| Orbital Diseases | 1 | 2014 | 21 | 0.110 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 27 | 0.070 |
Why?
|
| Blood Circulation | 1 | 2005 | 30 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2005 | 91 | 0.060 |
Why?
|
| Middle Aged | 2 | 2015 | 26191 | 0.060 |
Why?
|
| Humans | 9 | 2015 | 90039 | 0.060 |
Why?
|
| Perfusion | 1 | 2005 | 253 | 0.060 |
Why?
|
| Gaucher Disease | 1 | 2003 | 4 | 0.050 |
Why?
|
| Splenic Neoplasms | 1 | 2003 | 17 | 0.050 |
Why?
|
| Male | 4 | 2015 | 42721 | 0.050 |
Why?
|
| Epoetin Alfa | 1 | 2001 | 2 | 0.050 |
Why?
|
| Filgrastim | 1 | 2001 | 57 | 0.050 |
Why?
|
| Leukopenia | 1 | 2001 | 66 | 0.050 |
Why?
|
| Lymphoma | 1 | 2003 | 266 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2005 | 1066 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2001 | 90 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 166 | 0.050 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2000 | 9 | 0.050 |
Why?
|
| Polycythemia Vera | 1 | 2000 | 23 | 0.040 |
Why?
|
| Erythrocyte Count | 1 | 1999 | 22 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 1008 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 1999 | 67 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 270 | 0.040 |
Why?
|
| Hemoglobins | 1 | 1999 | 193 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 662 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 450 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 983 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 690 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 6790 | 0.020 |
Why?
|
| Aged | 3 | 2003 | 19280 | 0.020 |
Why?
|
| Female | 3 | 2014 | 46635 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 46 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2005 | 61 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 1999 | 9246 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2005 | 426 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3483 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 9355 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 2000 | 79 | 0.010 |
Why?
|
| Cough | 1 | 2000 | 55 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2000 | 296 | 0.010 |
Why?
|
| Fever | 1 | 2000 | 127 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2588 | 0.010 |
Why?
|
| Pain | 1 | 2000 | 400 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 3022 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 2507 | 0.010 |
Why?
|